Alnylam Pharmaceuticals (Nasdaq: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.
Recent Mentions on Fool.com
- Alnylam: The Best Hepatitis B Play?
- Monday?s Top Health Care Stories: Tesaro, Alnylam, Allergan, and Valeant
- Will These 3 Biotechs Bounce Back?
- Today?s Top Biotech Stories: MannKind, GSK, Myriad, and Alnylam
- Why American Capital Ltd., Alnylam Pharmaceuticals Inc., and Micron Technology Inc. are Today's 3 Be